Stockreport

Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing [Yahoo! Finance]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF Morgan and Bristol Myers Squibb that you may have missed from earlier this week. Takeda Pharmaceutical has paid $100 million for an exclusive option to license a blood [Read more]